A-Share Announcement Highlights | Shanghai Awinic Technology (688798.SH) to Acquire Yutai Semiconductor via Share Issuance and Cash Payment; Trading Suspended from November 10

Today's Focus 1. Shanghai Awinic Technology: Plans to acquire equity in Yutai Semiconductor via share issuance and cash payment; trading suspended from November 10 Shanghai Awinic Technology (688798.SH) announced that the company is planning to acquire equity in Yutai Semiconductor Co., Ltd. by issuing shares and paying cash, and to raise supporting funds. Based on preliminary estimates, this may constitute a major asset restructuring, will not result in a change of actual controller, and does not constitute a restructuring listing. Due to the uncertainty of the matter, the company's shares and convertible bonds "Awinic Convertible Bonds" will be suspended from trading and conversion will be suspended from market open on November 10, 2026, with the suspension expected to last no more than 10 trading days. 2. Hangzhou Tigermed Consulting: Transfers 64.48% equity in FRONTAGE, retains domestic business, divests overseas laboratories Hangzhou Tigermed Consulting (300347.SZ) announced that its wholly-owned subsidiary Hong Kong Tigermed, CRL, and a trust related to Dr. Li Song will jointly contribute to establish SanRex, to privatize the Hong Kong-listed controlled subsidiary FRONTAGE by way of a scheme of arrangement, and simultaneously implement a spin-off: the initial transaction price of the target business is US$470 million, the overseas non-target business is US$84.4 million, and the domestic non-target business is US$205.5 million. Before the transaction, the company held a total of 64.48% of FRONTAGE's shares; after completion, it will no longer hold any shares and will only retain the domestic non-target business. During the privatization stage, it can receive cash consideration of HK$535.67 million (approximately RMB461.2 million) corresponding to the cancellation of 11.09% of shares. The transaction is expected to generate profit accounting for more than 50% of the audited net profit of the most recent fiscal year, and still requires shareholder meeting approval. 3. Tech-Bank Food: Tongwei Group selected as industrial investor, acquires 1.470 billion shares of capitalized shares for RMB1.441 billion Tech-Bank Food (002124.SZ) announced that after comprehensive evaluation by the investor review committee, Tongwei Group Co., Ltd. was confirmed as the selected industrial investor and a "Restructuring Investment Agreement" was signed. Based on the existing total share capital, a capital reserve capitalization will be implemented at 13.8 shares for every 10 shares, adding a total of 3,066,268,688 shares, of which Tongwei Group will conditionally receive 1,470,120,300 shares and pay investment funds of RMB1.441 billion, at a per-share consideration of RMB0.98. The remaining capitalized shares will be used to settle bankruptcy claims. The Ningbo Intermediate People's Court has permitted an extension of the pre-restructuring period to May 9, 2027. If the court rules to accept the restructuring, the stock will be subject to delisting risk warning, and there remains the risk that the restructuring fails, bankruptcy is declared, and the stock is delisted. 4. Guangzhou Baiyunshan Pharmaceutical Holdings: Guangzhou Pharmaceutical listed to bring in strategic investors, raising no more than RMB6 billion, stake to fall to 53.23% Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that its controlled subsidiary Guangzhou Pharmaceutical Co., Ltd. plans to publicly list on the Guangzhou Equity Exchange to introduce strategic investors and implement a targeted share issuance, planning to solicit no more than 15 investors, with an issue price of no less than RMB3.46 per share, targeted issuance of no more than 1,734,104,046 shares, and fundraising scale of no more than RMB6 billion. The company does not enjoy preemptive subscription rights. After the capital increase is completed, its stake is expected to be no less than 53.23%, and it will remain the controlling shareholder, with the scope of consolidated statements unchanged. This matter still requires shareholder meeting approval, and whether investors can be successfully introduced and the final fundraising amount remain uncertain. 5. ChengDu Sheng Nuo Biotec: Customer return and refund of US$24.9596 million, expected to reduce net profit attributable to parent by RMB84.2466 million ChengDu Sheng Nuo Biotec (688117.SH) announced that the company and its wholly-owned subsidiary Sheng Nuo Pharmaceutical signed a "Return and Refund Agreement" with U.S. customer A, agreeing to return part of the polypeptide API under two purchase orders dated February 6, 2025 and November 24, 2025, and the company will refund the purchase price in installments in U.S. dollars totaling US$24.9596 million. After the refund under the agreement, it is expected to reduce the current year's main business revenue by RMB163.2411 million, total profit by RMB99.1137 million, and net profit attributable to parent by RMB84.2466 million, and does not involve adjustments to accounting data for the first three quarters of 2026 and prior years. The company's revenue for the first three quarters was RMB741.2052 million, and net profit attributable to parent was RMB170.5896 million. 6. Beijing Huaru Technology: Banned from participating in military materials, engineering, and services procurement activities for 5 years Beijing Huaru Technology (301302.SZ) announced that the company received the "Prohibitive Handling Regarding Beijing Huaru Technology Co., Ltd." published on the military procurement website. This handling is the disposition opinion regarding the suspension matter of March 31, 2026, and the result is that the company is prohibited from participating in military materials, engineering, and services procurement activities from November 22, 2023 to November 22, 2028, with the effective scope covering the entire military and the effective category covering all categories of projects. Legal representative Han Chao is similarly prohibited from March 31, 2026 to March 31, 2029. The main violation is "other; according to notifications from relevant departments, violations exist." 7. Pinlive Foods: Consortium confirmed as restructuring investor of Taishan Beer, may constitute a major asset restructuring Pinlive Foods (300892.SZ) announced that the consortium formed by the company, Tai'an Zhiyi Culture Investment Partnership, and Tai'an Xinyi Culture Investment Partnership has been confirmed as the restructuring investor of Shandong Taishan Beer Co., Ltd. Taishan Beer and four affiliated companies including Tai'an Taishan Beer Logistics and Foshan Taishan Beer were ruled by the Tai'an Taishan District People's Court on April 23, 2026 to undergo substantive consolidated bankruptcy restructuring. Subsequently, agreement with creditors on the restructuring plan and court approval are still required, and this investment may carry the risk of constituting a major asset restructuring. Operating Performance 1. Daqin Railway: October cargo transport volume on the Daqin Line was 32.02 million tonnes, down 1.51% year on year Daqin Railway (601006.SH) announced that average daily transport volume was 1.0329 million tonnes, and the cumulative volume from January to October was 329.59 million tonnes, up 3.52% year on year. 2. Yunnan Shennong Agricultural Industry Group: October sales of commercial pigs 428,400 head, revenue RMB591 million Yunnan Shennong Agricultural Industry Group (605296.SH) announced that sales volume rose 55.90% year on year and revenue rose 49.24% year on year, with an average price of RMB9.83/kg. 3. Hunan New Wellful: October sales of live pigs 384,700 head, down 36.93% year on year Hunan New Wellful (600975.SH) announced that among them, commercial pigs were 180,000 head, and the sales price of commercial pigs was RMB9.69/kg. Share Buybacks & Increases/Decreases in Holdings 1. Wus Printed Circuit: Plans to buy back RMB500 million to RMB1 billion; actual controller to increase holdings by RMB20 million to RMB30 million concurrently Wus Printed Circuit (002463.SZ) announced that the buyback price will not exceed RMB156.70 per share, and Hepai Youlian will increase holdings within 6 months. 2. Advanced Micro-Fabrication Equipment Inc. China: First buyback of 79,600 shares, transaction amount RMB19.9856 million Advanced Micro-Fabrication Equipment Inc. China (688012.SH) announced that the transaction price was RMB247.51 to RMB257.00 per share, and the total plan size is RMB400 million to RMB500 million. 3. Guangzhou Tinci Materials Technology: Controlling shareholder and chairman Xu Jinfu proposes buyback of RMB50 million to RMB100 million Guangzhou Tinci Materials Technology (002709.SZ) announced that the price will not exceed 150% of the average price over the previous 30 trading days, for incentives or cancellation. 4. Shengyi Electronics: Shareholder Dongguan Sci-Tech Investment Group plans to increase holdings by RMB50 million to RMB100 million Shengyi Electronics (688183.SH) announced that before the increase, it and concert parties held a total of 7.73%, to be implemented within 6 months. Major Contracts 1. Traffic Control Technology: Wins bid for Shuohuang Railway locomotive moving block renovation project, amount RMB154.2 million Traffic Control Technology (688015.SH) announced that it has received the notice of award but has not yet signed a formal contract, with a delivery period of 90 days. 2. Chongqing Construction Engineering Group: Consortium wins bid for Wansheng Economic Development Zone EPC project, bid price approximately RMB494 million Chongqing Construction Engineering Group (600939.SH) announced that the company is the consortium leader and will undertake construction volume of approximately RMB490 million, with a construction period of 730 days.